Linzagolix Offers Sustained Reduction of Endometriosis Pain, Trial Shows
News
ObsEva‘s linzagolix lessened endometriosis-associated pelvic pain and increased the quality of life of endometriosis patients in a sustained, long-term manner, according to results of the Phase 2b EDELWEISS trial. Linzagolix ... Read more